Navigation Links
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
Date:2/9/2009

- Conference Call at 10:00 A.M. Today to Discuss Results -

EXTON, Pa., Feb. 9 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint. In the primary analysis, there was no statistically significant difference between maribavir and placebo in reducing the rate of CMV disease. In addition, the study failed to meet its key secondary endpoints. Maribavir was generally well tolerated in this clinical study.

"We are extremely disappointed by the outcome of this pivotal study," said Vincent J. Milano, ViroPharma's president and chief executive officer. "We just received these data and there are far more questions than answers; we still have a significant amount of work to do to fully understand this outcome and its impact on the overall program. Our disappointment is no doubt shared by physicians and transplant patients, who must today contend with CMV disease."

The primary endpoint of this Phase 3 study was the incidence of CMV disease, confirmed by an independent endpoint committee, within 6 months post-transplant. The incidence of CMV disease within 6 months was 4.4 percent for maribavir compared to 4.8 percent for placebo (P=0.79). The first of four key secondary endpoints was the rate of initiation of anti-CMV treatment within 6 months, which was 37.9 percent for maribavir compared to 40.5 percent for placebo (P=0.49). In addition, the incidence of graft-versus-host disease, mortality and CMV disease-free survival was comparable between the groups.

Conference Call and Webcast

ViroPharma is hosting a live teleconference and webcast with se
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
2. ViroPharma Provides Update on Vancocin(R)
3. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
4. ViroPharma To Present At The 20th Annual Piper Jaffray Healthcare Conference
5. ViroPharma to Discuss Commercialization and Launch of Cinryze(TM) on November 5, 2008
6. ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
7. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
8. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
9. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
10. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
11. ViroPharma Provides Update on Vancocin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
Breaking Medicine News(10 mins):Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... suggest that hormones in saliva may be a biological ... result of chronic bullying by peers. ... in the early recognition and intervention of long-term psychological ... self-reported either by students or observed by teachers,' said ...
... of Rhode Island's Cancer Prevention Research Center will bring ... substance abuse . The outcome is based on decades ... and other high-risk behaviors of teenagers and adults. ... from the National Institute of Drug Abuse to support ...
... US may soon impact the quality of patient care ... a report. ,Without intervention, the number of ... while demand will increase by 35 percent over the ... ,The decline in the number of qualified ...
... President, Dr Choong-Siew Yong, today warned consumers could be seriously ... ,In a submission to Food Standards Australia and New ... manufacturers are likely to confuse consumers and may even contribute ... to put health claims on labels to encourage consumers to ...
... insensitive caption for the picture of an abandoned baby in Melbourne ... left in a cardboard box kept by a Japanese hospital for ... Jikei Hospital in the southern city of Kumamoto to discourage abortions ... ,A small hatch on the side of the hospital has ...
... This high degree of trust and confidence in doctors reflects ... survey reflects the immense efforts from doctors to improve ... the financial pressures placed upon the health service. ... this survey, the majority of respondents have answered that doctors ...
Cached Medicine News:Health News:Saliva Helps to Identify Child Victims of Chronic Bullying 2Health News:New Substance Use Prevention Program Being Developed 2Health News:New Substance Use Prevention Program Being Developed 3Health News:New Substance Use Prevention Program Being Developed 4Health News:America on Brink of Allergy Crisis 2Health News:Three-year-old Abandoned in Box Meant for Unwanted Babies in Japan 2
(Date:1/22/2015)... UPI ), a medical device company that develops, manufactures ... today reported financial results for the fiscal 2015 third ... the Company,s Urgent ®  PC Neuromodulation System grew 14.5% ... compared to $3.9 million in the third quarter of ...
(Date:1/22/2015)... MINNEAPOLIS , Jan. 22, 2015  Bio-Techne Corporation (NASDAQ: ... launched Ella, the first member of the new Simple ... ProteinSimple brand.  This launch represents the re-branding of the ... The Simple Plex platform is a transformative immunoassay technology ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and ... the addition of the "Microbiology Testing/Clinical Microbiology ... - Global Forecast to 2019" report to ... a wide array of techniques for the detection ...
Breaking Medicine Technology:Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 3
... surgical instrument, the HipSextant™ Navigation System, was used commercially ... a New York hospital. The system is designed to ... socket component—into the pelvis with greater precision during hip ... cup malposition occurs in 50-80% of hip surgeries performed ...
... Mass., Oct. 18, 2011 Boston Scientific Corporation (NYSE: ... clinical trial to evaluate its WallFlex® Biliary RX Fully ... strictures (narrowing or blockages).  This multi-center, prospective study enrolled ...  Lead Investigators in the study are Professor Jacques Deviere, ...
Cached Medicine Technology:HipSextant™ Navigation System Receives Its First Commercial Use 2HipSextant™ Navigation System Receives Its First Commercial Use 3Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent 2Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent 3Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent 4
... Store 200 to 350 Liters of pure ... and Distribution of Purified Water,Millipores compact S.D.S. ... store 200 to 350 liters of purified ... and to maintain consistent purity of stored ...
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
... has developed a range of Milli-Q ... specific water quality requirements. Each of ... designed to specifically target contaminants detrimental ... molecular biology and ICP-MS. The systems ...
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
Medicine Products: